RxDoctor Payments Data

Roger Stimpson, DO

Vascular & Interventional Radiology · Murray, UTNPI 1447661053

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Biocompatibles, Inc. at 29.4% of the total. Reporting peaked in 2019 at $3,448 and has fallen 96.6% since, to $118 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in UT, where the typical reported total is $5,604.

$5,604in general payments, 2019–2025

Across 80 payments — averaging $70.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biocompatibles, Inc.$2K
  • Penumbra, Inc.$1K
  • Inari Medical, Inc.$905
  • Endologix LLC$838
  • Merit Medical Systems Inc$508
  • Boston Scientific$354
  • plus $242 from 8 others

What the payments were for

  • Travel & lodging$2,56446%
  • Food & beverage$3,03954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,604 in reported general payments places this provider in the 50th percentile of 38 vascular & interventional radiology providers in Utah.

See all vascular & interventional radiology providers in Utah

Medicare billing

Part B allowed, 2024
$82,285
Medicare patients
582
Services billed
3,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →